BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34082953)

  • 1. In vivo therapeutic evaluation of a novel bis-lawsone derivative against tumor following delivery using mesoporous silica nanoparticle based redox-responsive drug delivery system.
    Kundu M; Sadhukhan P; Ghosh N; Ghosh S; Chatterjee S; Das J; Brahmachari G; Sil PC
    Mater Sci Eng C Mater Biol Appl; 2021 Jul; 126():112142. PubMed ID: 34082953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
    Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
    Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor targeted delivery of umbelliferone via a smart mesoporous silica nanoparticles controlled-release drug delivery system for increased anticancer efficiency.
    Kundu M; Chatterjee S; Ghosh N; Manna P; Das J; Sil PC
    Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111239. PubMed ID: 32806268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DPP-Cu
    Chen W; Ma M; Lai Q; Zhang Y; Liu Z
    Curr Med Chem; 2023; 30(28):3249-3260. PubMed ID: 36221869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional Redox-Responsive Mesoporous Silica Nanoparticles for Efficient Targeting Drug Delivery and Magnetic Resonance Imaging.
    Chen L; Zhou X; Nie W; Zhang Q; Wang W; Zhang Y; He C
    ACS Appl Mater Interfaces; 2016 Dec; 8(49):33829-33841. PubMed ID: 27960384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optimized mesoporous silica nanosphere-based carrier system with chemically removable Au nanoparticle caps for redox-stimulated and targeted drug delivery.
    Zhang L; Wei F; Al-Ammari A; Sun D
    Nanotechnology; 2020 Nov; 31(47):475102. PubMed ID: 32413886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
    Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H
    Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of anti-neoplastic effects of cuminaldehyde against breast cancer via mesoporous silica nanoparticle based targeted drug delivery system.
    Ghosh S; Kundu M; Dutta S; Mahalanobish S; Ghosh N; Das J; Sil PC
    Life Sci; 2022 Jun; 298():120525. PubMed ID: 35378139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging.
    Croissant JG; Zhang D; Alsaiari S; Lu J; Deng L; Tamanoi F; AlMalik AM; Zink JI; Khashab NM
    J Control Release; 2016 May; 229():183-191. PubMed ID: 27016140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
    Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice.
    Ding Z; Wang D; Shi W; Yang X; Duan S; Mo F; Hou X; Liu A; Lu X
    Int J Nanomedicine; 2020; 15():8383-8400. PubMed ID: 33149582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pH-responsive mesoporous silica nanoparticle-based drug delivery system for targeted breast cancer therapy.
    Chang J; Mo L; Song J; Wang X; Liu H; Meng C; Wu Y
    J Mater Chem B; 2022 May; 10(17):3375-3385. PubMed ID: 35388835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A convergent fabrication of pH and redox dual-responsive hybrids of mesoporous silica nanoparticles for the treatment of breast cancer.
    Zhu L; Wang S
    J Biomater Sci Polym Ed; 2023 Feb; 34(2):147-165. PubMed ID: 36136033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold nanoparticle-gated mesoporous silica as redox-triggered drug delivery for chemo-photothermal synergistic therapy.
    Yang Y; Lin Y; Di D; Zhang X; Wang D; Zhao Q; Wang S
    J Colloid Interface Sci; 2017 Dec; 508():323-331. PubMed ID: 28843922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold-capped mesoporous silica nanoparticles as an excellent enzyme-responsive nanocarrier for controlled doxorubicin delivery.
    Eskandari P; Bigdeli B; Porgham Daryasari M; Baharifar H; Bazri B; Shourian M; Amani A; Sadighi A; Goliaei B; Khoobi M; Saboury AA
    J Drug Target; 2019 Dec; 27(10):1084-1093. PubMed ID: 30900473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
    Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
    J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinatory Cancer Therapeutics with Nanoceria-Capped Mesoporous Silica Nanocarriers through pH-triggered Drug Release and Redox Activity.
    Singh RK; Patel KD; Mahapatra C; Parthiban SP; Kim TH; Kim HW
    ACS Appl Mater Interfaces; 2019 Jan; 11(1):288-299. PubMed ID: 30539634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous silica nanoparticle-supported nanocarriers with enhanced drug loading, encapsulation stability, and targeting efficiency.
    Oh JY; Yang G; Choi E; Ryu JH
    Biomater Sci; 2022 Mar; 10(6):1448-1455. PubMed ID: 35229845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoplatform based on GSH-responsive mesoporous silica nanoparticles for cancer therapy and mitochondrial targeted imaging.
    He H; Meng S; Li H; Yang Q; Xu Z; Chen X; Sun Z; Jiang B; Li C
    Mikrochim Acta; 2021 Apr; 188(5):154. PubMed ID: 33821295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.